YAKULT HONSHA CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,894 JPY | +0.45% |
|
-4.38% | -8.60% |
| Sales 2024 | 503B 3.21B | Sales 2025 * | 521B 3.32B | Capitalization | 874B 5.57B |
|---|---|---|---|---|---|
| Net income 2024 | 51.01B 325M | Net income 2025 * | 53.8B 343M | EV / Sales 2024 | 1.9 x |
| Net cash position 2024 * | 162B 1.03B | Net cash position 2025 * | 186B 1.18B | EV / Sales 2025 * | 1.32 x |
| P/E ratio 2024 |
19
x | P/E ratio 2025 * |
16.4
x | Employees | 29,880 |
| Yield 2024 |
1.78% | Yield 2025 * |
2.22% | Free-Float | 71.96% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.45% | ||
| 1 week | -1.40% | ||
| Current month | -6.21% | ||
| 1 month | -6.21% | ||
| 3 months | -11.40% | ||
| 6 months | -13.57% | ||
| Current year | -8.60% |
1 week
2 866.00
2 965.00
1 month
2 866.003 250.00
Current year
2 866.003 334.00
1 year
2 866.004 796.00
3 years
2 730.005 215.00
5 years
2 407.505 215.00
10 years
2 252.505 215.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hiroshi Narita
PSD | President | 72 | 74-03-31 |
| Chief Administrative Officer | 72 | 77-03-31 | |
Hideaki Hoshiko
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ryuji Yasuda
BRD | Director/Board Member | 78 | 09-05-31 |
| Chief Administrative Officer | 72 | 77-03-31 | |
Hiroshi Narita
PSD | President | 72 | 74-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.15% | 12 M€ | +9.45% | ||
| 0.51% | 14 M€ | +18.19% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 2,894 | +0.45% | 1 298 400 |
| 24-05-27 | 2,882 | -1.01% | 2,144,700 |
| 24-05-24 | 2,911 | -0.95% | 1,319,300 |
| 24-05-23 | 2,939 | +0.14% | 1,261,400 |
| 24-05-22 | 2,935 | -0.02% | 1,659,400 |
Delayed Quote Japan Exchange, May 28, 2024 at 02:00 am EDT
More quotes
YAKULT HONSHA CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of dairy products and pharmaceuticals. The Company operates in three business segments. The Beverages and Food Manufacturing and Sale segment is engaged in the manufacture and sale of dairy products, beverages, noodles and healthy food, the purchase and sale of materials, as well as the transportation business. The Company operates business in Japan, the Americas, Europe, Asia and Oceania. The Pharmaceuticals Manufacturing and Sale segment is engaged in the manufacture and sale of anticancer drugs and other ethical drugs. The Others segment is engaged in the production and sale of cosmetics, as well as the operation of professional baseball clubs.
Sector
Food Processing
Calendar
2024-07-25
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
2,882
JPY
Average target price
3,489
JPY
Spread / Average Target
+21.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.60% | 5.57B | |
| -5.40% | 265B | |
| -5.70% | 91.61B | |
| -3.06% | 43.53B | |
| +1.02% | 41.41B | |
| +5.66% | 39.84B | |
| +4.85% | 38.56B | |
| -16.24% | 29.91B | |
| -7.58% | 28.53B | |
| +14.61% | 25.94B |
- Stock Market
- Equities
- 2267 Stock
